| Literature DB >> 34320369 |
Kellie A Lemoine1, Julianna M Fassas1, Shirag H Ohannesian1, Nicole H Purcell2.
Abstract
PH domain leucine-rich repeat protein phosphatase (PHLPP) is a family of enzymes made up of two isoforms (PHLPP1 and PHLPP2), whose actions modulate intracellular activity via the dephosphorylation of specific serine/threonine (Ser/Thr) residues on proteins such as Akt. Recent data generated in our lab, supported by findings from others, implicates the divergent roles of PHLPP1 and PHLPP2 in maintaining cellular homeostasis since dysregulation of these enzymes has been linked to various pathological states including cardiovascular disease, diabetes, ischemia/reperfusion injury, musculoskeletal disease, and cancer. Therefore, development of therapies to modulate specific isoforms of PHLPP could prove to be therapeutically beneficial in several diseases especially those targeting the cardiovascular system. This review is intended to provide a comprehensive summary of current literature detailing the role of the PHLPP isoforms in the development and progression of heart disease.Entities:
Keywords: Akt; Cardiac hypertrophy; Cardiovascular disease; PHLPP; Phosphatase; Serine/threonine
Mesh：
Substances：
Year: 2021 PMID： 34320369 PMCID： PMC8403656 DOI： 10.1016/j.cellsig.2021.110097
Source DB: PubMed Journal: Cell Signal ISSN： 0898-6568 Impact factor: 4.850